Department of Pathological Anatomy

Medicine & Life Sciences

1. Indonesia 100%
2. Breast Neoplasms 39%
3. Neoplasms 37%
4. Uterine Cervical Neoplasms 29%
5. Colorectal Neoplasms 21%
6. Carcinoma 19%
7. Neoplasm Metastasis 18%
8. Skin Neoplasms 17%
9. Immunohistochemistry 17%
10. Bone and Bones 16%
11. Staining and Labeling 16%
12. Cell Line 15%
13. Lymphoma 15%
14. Colon 15%
15. Apoptosis 15%
16. Dextran Sulfate 15%
17. Squamous Cell Carcinoma 14%
18. Japan 14%
19. Caspase 3 14%
20. Pleural Empyema 14%
21. Biopsy 13%
22. Human Herpesvirus 4 13%
23. Proteins 11%
24. Catenins 11%
25. Lymph Nodes 11%
26. Cell Biology 11%
27. Carcinogenesis 10%
28. Control Groups 10%
29. Liver 10%
30. Adenocarcinoma 10%
31. Osteosarcoma 9%
32. Melanoma 9%
33. Mutation 9%
34. Hepatocellular Carcinoma 9%
35. Paraffin 9%
36. Pathology 8%
37. Mesenchymal Stem Cells 8%
38. Ductal Carcinoma 8%
39. Survival 8%
40. Therapeutics 8%
41. Inflammation 8%
42. Case-Control Studies 8%
43. antimycin 8%
44. Sprague Dawley Rats 8%
45. Anti-Inflammatory Agents 8%
46. Fibrosis 8%
47. Ethanol 8%
48. Fruit 7%
49. Population 7%
50. Epidemiologic Studies 7%
51. Wistar Rats 7%
52. Lymphoma, Large B-Cell, Diffuse 7%
53. B-Lymphocytes 7%
54. Lymphocytes 7%
55. Chronic Hepatitis B 7%
56. Skin 7%
57. Basal Cell Carcinoma 7%
58. Drug Therapy 7%
59. Endometrioid Carcinoma 7%
60. Genes 7%
61. Cell Proliferation 7%
62. Chitosan 7%
63. Natural Killer Cells 7%
64. Embryonal Rhabdomyosarcoma 7%
65. Keratin-19 7%
66. nucleolar organizer region associated proteins 7%
67. Eosine Yellowish-(YS) 6%
68. Cancer-Associated Fibroblasts 6%
69. Cyclooxygenase 2 6%
70. Cadherins 6%
71. Colonoscopy 6%
72. Epidemiology 6%
73. Cancer Care Facilities 6%
74. DNA 6%
75. Recurrence 6%
76. Polyps 6%
77. Incidence 6%
78. Mitosis 6%
79. Fetal Blood 6%
80. Wounds and Injuries 6%
81. T-Cell Lymphoma 6%
82. Liposarcoma 6%
83. Middle Cerebral Artery Infarction 6%
84. Sarcoma 6%
85. Breast 6%
86. T-Lymphocytes 6%
87. General Hospitals 6%
88. Limb Salvage 6%
89. Contraceptive Agents 6%
90. Blood Cells 6%
91. Sensitivity and Specificity 6%
92. Endometrium 6%
93. Ovarian Epithelial Carcinoma 6%
94. NF-kappa B 6%
95. Fas Ligand Protein 6%
96. Wound Healing 5%
97. Hemorrhage 5%
98. Cross-Sectional Studies 5%
99. Messenger RNA 5%
100. Nitric Oxide Synthase Type II 5%